Files
Download Full Text (406 KB)
Contents
- Biomarker-Driven Clinical Trials may Improve Personalized Treatment for Patients With Lung Cancer: Innovative clinical trials that assign patients to treatment arms based on tumor biomarkers could lead to increase treatment options for patients with lung cancer
- New Antibody-Chemotherapy Combinations Show Promise Against Acute Lymphoblastic Leukemia: Two investigational agents-inotuzumab and ofatumumab-shows promise when combined with cytotoxic chemotherapy drugs for the treatment of acute lymphoblastic leukemia (ALL) in adults
- Deep Inspiration Breath Hold Protects Against Radiation-Induced Cardiotoxicity in Patients With Left-Sided Breast cancers: Patients with lest-sided breast cancers have an increased risk of heart damage from adjuvant radiation therapy given after lumpectomy or mastectomy
- HOUSE CALL: Books Can Help Patients Deal With Cancer-Fiction and nonfiction can provide encouragement and education
- INBRIEF: Large-Scale Molecular Data Analysis Yields Multiple Benefits
Publication Date
9-1-2014
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Papadimitakopoulou, Vali; Jabbour, Elias; Kantarjian, Hagop, 1952-; Smith, Benjamin; Katz, Rebecca; Edelson, Mat; Villejo, Louise; Servan-Schreiber, David; Geiger, Chris (Christopher); Armstrong, Lance; Jenkins, Sally (Novelist); Green, John; Picoult, Jodi, 1966-; Mukherjee, Siddhartha; Liang, Han; Clinical Trials as Topic; Lung Neoplasms; Precision Medicine; Patients; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Antineoplastic Agents; Antibodies, Monoclonal; Breast Neoplasms; Radiotherapy; Breath Holding; Neoplasms; Books; Data Analysis; Models, Statistical.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Deming, Stephanie; Tutt, Bryan; Munch, Joe; and Deisigne, Jill, "OncoLog, Volume 59, Number 09, September 2014" (2014). OncoLog MD Anderson's Report to Physicians (All issues). 251.
https://openworks.mdanderson.org/oncolog/251
Conditions Governing Access
Open